Ambit

Healthcare technology for rare disease management

Morristown, New Jersey, United States

About Ambit

Ambit improves the diagnosis and management of rare diseases through a comprehensive platform designed for patients, caregivers, healthcare providers, and biopharmaceutical companies. The platform offers data, analytics, and testing services that help identify and diagnose patients, which is crucial for clinical trials and treatment access. Ambit partners with Patient Advocacy Groups and healthcare providers to enhance its services and support patient care. The company's goal is to streamline access to appropriate care and treatments for individuals affected by rare diseases.

Morristown, New JerseyHeadquarters
2021Year Founded
$8.9MTotal Funding
DEBTCompany Stage
Biotechnology, HealthcareIndustries
51-200Employees

Risks

Emerging startups in rare diseases threaten Ambit's market share.
Rapid AI advancements may outpace Ambit's current platform capabilities.
Economic downturns could reduce biopharma investments in Ambit's partnerships.

Differentiation

Ambit focuses on rare diseases, a niche often underserved in healthcare.
The platform integrates data, analytics, and testing for comprehensive rare disease management.
Partnerships with Patient Advocacy Groups enhance patient connections and support.

Upsides

AI and machine learning integration boosts diagnostic accuracy on Ambit's platform.
Rising demand for personalized medicine aligns with Ambit's data-driven solutions.
Partnership with CustomerInsights.AI enhances Ambit's data management and commercial operations.

Funding

Total raised$8.94 M
StageDEBT
DEBT
7/31/2023
$2